back to overview


New investment in an Israeli based digital health company TytoCare

February 23, 2018 + Jessica Di Palo
5 Min read

MTIP Expands TytoCare Funding Round to $25M, Joining an International Syndicate for the telehealth Start-up.

Tytocare closes investment round

MTIP joins a large list of strategic and financial investors to expand a funding round for TytoCare, an Israel-based digital health company with breakthrough technology for conducting comprehensive examinations and telehealth visits, to $28M. Additional investors include Ping An Global Voyager Fund, Cambia Health Solutions, Walgreens, Orbimed, Fosun Pharma, LionBird and Qure.  As the sole European based investor, MTIP is working with TytoCare to help them expand in the European region.

Following its FDA clearance in late 2016, and the launch of its products in the United States in early 2017, TytoCare has gained significant traction with major US health systems, telehealth companies, large private practices and employers. TytoCare will use the additional funding to continue its expansion in the US market and enhance its product offerings and smart data analytics to empower both clinicians and consumers doing telehealth. The funds will also help TytoCare fulfil the demand for its products outside the US and penetrate both the Asian and European markets.

MTIP has played and will continue to play a vital role in opening doors and creating potential partnerships throughout Europe,” said Dedi Gilad, Co-Founder and CEO of TytoCare. “Building on the success and excitement for TytoCare in the US, we are pleased to be partnering with such a knowledgeable digital health investor whose unique position will help us further transform telehealth and reach more homes around the globe, especially in Europe.”

“TytoCare has an exceptional telehealth solution that will revolutionize how patients receive primary care,” said Dr Christoph Kausch Founding Partner and CEO of MTIP.  “The quality of the management team is exceptional and we look forward to taking part in TytoCare’s success.”

Bruce Meadows, the Fund’s Senior Investment Director, added that “TytoCare fits perfectly into MTIP’s digital health strategy.  Their connected suite of tools is at the intersection of telehealth and medical devices. Their ability to generate clinical quality data combined with machine learning produces better outcomes for patients and cost efficiency for healthcare systems.”

Share the Article


Dealroom Report: Tooling the Physicians of the Future

European startups addressing clinical capacity bottlenecks


MTIP Office Featured in Swiss Office Blog

MTIP Office Featured in Swiss Office Blog


Diversity, Equity, and Inclusion: The 3 Key Drivers for Success

We have talked with Caroline Noublanche, CEO of our portfolio company Apricity, about her company’s DEI efforts.


Growth Capital Decisions – An Interview with our Co-Founder & Managing Partner Dr. Christoph Kausch

Growth Capital Decisions


Rahel Hafner Receives Certificate in ESG Investing by CFA Institute

Rahel Hafner Receives Certificate in ESG Investing


What Makes a Great Founder/Investor Relationship?

Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva


MTIP’s HealthCare Clinic 2022

This year's HealthCare Clinic was held under the motto: "Surfing the Healthtech Waves of Change".


Christoph Kausch selected by Real Deals as most influential for 2022

Christoph Kausch named by Real Deals most influential for 2022


MTIP leads €17 million financing round in virtual fertility clinic Apricity

New MTIP investment


MTIP leads the €20 million growth financing round in LynxCare

Largest capital round ever in digital health in Belgium


Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development


The psychology of decision making

What makes a good investor?


Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage


MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!


Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!


MTIP invests in Mediktor

New investment in Mediktor


SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right


MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round


MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia


Private Equity 101: Part one – Glossary

Are you new to the healthtech space?


Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey


Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations


MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II